Featured Article
Category: News
Genetic Medicine And AMD Treatment; Genetic Screening And Glaucoma
CHICAGO – Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session Octo…
New CME Activity: Rethinking Ocular Antiinfectives, Issue 3
Featured Article
Beta Carotene And Retinitis Pigmentosa
CHICAGO-Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable r…
Genetic Medicine And AMD Treatment; Genetic Screening And Glaucoma
CHICAGO – Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session Octo…
AAO: Anti-VEGF Drugs Making Leap to Diabetic Eye Disease (CME/CE)
CHICAGO (MedPage Today) — Drugs approved for “wet” age-related macular degeneration also appeared to be effective in diabetic macular edema in several clinical studies, researchers said here.
AAO: Camera Chip Provides Sight in Retinitis Pigmentosa (CME/CE)
CHICAGO (MedPage Today) — A tiny array of light-sensing diodes restored a measure of sight to a small number of patients with retinitis pigmentosa, a researcher said here.
A Dry AMD Treatment? Some Long-Term Diabetics Escape PDR
CHICAGO-At the American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting today, researchers report progress on two top eye disease challenges: treating advanced “dry” age-related macular degeneration, a…
Beta Carotene And Retinitis Pigmentosa
CHICAGO-Today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting includes a report on beta carotene’s ability to improve vision in people with certain incurable r…
Blood Pressure, Glaucoma Links In Migraine Patients; Eye Care Goes Digital And Mobile
CHICAGO-Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today’s Scientific Program, to be presented at the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of O…
Genetic Medicine And AMD Treatment; Genetic Screening And Glaucoma
CHICAGO – Genetic medicine is the focus of two presentations at today’s Scientific Program of the 2010 American Academy of Ophthalmology (AAO) – Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting. The AAO-MEACO meeting is in session Octo…
AAO: Camera Chip Provides Sight In Retinitis Pigmentosa
A tiny array of light-sensing diodes restored a measure of sight to a small number of patients with retinitis pigmentosa, a researcher said here.
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY(TM)
ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09% as a once-daily prescriptio…
Gene Therapy A Future Possibility In Glaucoma, Clinician Says
With 14 regions of the genome associated with primary open-angle glaucoma known and four genes identified, possible applications for genetics in glaucoma could include an additional therapeutic option, a clinician said here.
Push And Pull Get Eyes To Work Together
Researchers appear to have found a better way to correct sensory eye dominance, a condition in which an imbalance between the eyes compromises fine depth perception. The key is a push-pull training method in which the weak eye is made to work while vis…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Carl Zeiss Meditec Introduces New Innovations: ‘Creating What’s To Come’ At AAO 2010
AAO Booth #1408 – Carl Zeiss Meditec today unveiled its newest product innovations at the 2010 American Academy of Ophthalmology annual meeting in Chicago. Powered by the FORUM Ophthalmic Data Management System, the new Glaucoma Workplace features FORU…
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY
ISTA Pharmaceuticals, Inc. , today announced the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for BROMDAY (bromfenac ophthalmic solution) 0.09% as a once-daily prescription eye drop for the…
Issuing First Report On NTDs, WHO Aims For ‘Complete Control’ By 2015
The WHO “said on Thursday that it was aiming for ‘complete control’ by 2015 of tropical diseases that affect one billion impoverished people” and kill an estimated 534,000 people each year, Agence France-Presse reports (10/14)…